P
Peter G. Gibson
Researcher at University of Newcastle
Publications - 774
Citations - 53254
Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
Global Physiology and Pathophysiology of Cough: Part 2. Demographic and Clinical Considerations: CHEST Expert Panel Report.
Lorcan McGarvey,Bruce K. Rubin,Satoru Ebihara,Karen Wheeler Hegland,Alycia Rivet,Richard S. Irwin,Donald C. Bolser,Anne B. Chang,Peter G. Gibson,Stuart B. Mazzone,Chest Expert Cough Panel +10 more
TL;DR: A review of the literature was conducted using PubMed and MEDLINE databases from 1951 to 2019 using prespecified search terms as discussed by the authors, which complemented part one on basic phenomenology of cough by providing an extended clinical picture of cough along with the factors that alter cough mechanics and efficiency in patients.
Journal ArticleDOI
Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma
TL;DR: In this article , a multivariate logistic regression was used to determine clinical characteristics associated with anxiety and depressive symptoms in severe asthma patients, including dyspnoea, dysfunctional breathing, and obesity.
Proceedings ArticleDOI
FeNO-guided management of asthma during pregnancy reduces respiratory symptoms and asthma diagnosis in childhood
Matthew Morten,Adam Collison,Joseph Meredith,Vanessa E. Murphy,Paul Robinson,Peter G. Gibson,Joerg Mattes +6 more
TL;DR: FeNO-guided management of asthma during pregnancy reduces respiratory symptoms and asthma diagnosis in the offspring at preschool age, and lung function was measured using impulse oscillometry.
Journal ArticleDOI
Asthma 2014: from monoclonals to the microbiome
TL;DR: Although ARDS remains a challenge because of the heterogeneity of the patient population, recent studies suggest that important advances are being made to improve patient outcome and to provide insights into the pathogenesis of the syndrome.